SARAH MCGREW: Open Payments
NPI 1902497837 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 73 payments from 16 companies in 2025. Trend: 2023 $556 · 2024 $1,073 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $175 |
| PFIZER INC. | 28 | $168 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| Sumitomo Pharma America, Inc. | 5 | $84 |
| Novo Nordisk Inc | 5 | $83 |
| Lilly USA, LLC | 4 | $77 |
| Exact Sciences Corporation | 3 | $55 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: LEQVIO, NURTEC ODT, UBRELVY, GEMTESA, Wegovy, QULIPTA, MOUNJARO, ELIQUIS.
Industry payments across MO — which companies pay providers there.
